NCT01614951View on ClinicalTrials.gov

The Pulmonary Protection Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Chronic Obstructive Lung Disease
Interventions
PROCEDURE

Perfusion of the lungs

Pulmonary perfusion with oxygenated blood during ECC.

DRUG

HTK Custodiol

Pulmoplegia before ECC.

OTHER

Standard ECC

ECC after standard procedure

Trial Locations (1)

2200

Rigshospitalet, Copenhagen N

All Listed Sponsors
collaborator

Lundbeck Foundation

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT01614951 - The Pulmonary Protection Trial | Biotech Hunter | Biotech Hunter